化合物简介
Orteronel (TAK-700) is a non-steroidal antiandrogen that was being developed for the treatment of cancer by Takeda Pharmaceutical Company in conjunction with Millennium Pharmaceuticals. It completed two phase III clinical trials for metastatic, hormone-refractory prostate cancer but failed to extend overall survival rates, and development was voluntarily terminated as a result.
基本信息
中文名称
Orteronel; 6-[(7S)-7-羟基-6,7-二氢-5H-吡咯并[1,2-c]咪唑-7-基]-N-甲基-2-萘甲酰胺
英文名称
6-[(7S)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide
中文别名
英文别名
TAK-700-Orteronel、TAK 700、Orteronel
CAS号
566939-85-3
分子式
C18H17N3O2
分子量
307.346
精确质量
307.132
PSA
67.15
LOGP
2.4264
合成路线
上游原料
共找到20个上游原料 >